Skip to main content
Top
Published in: Rheumatology International 12/2010

01-11-2010 | Letter to the Editor

Dietary flavonoid apigenin inhibits endothelin-1-induced contraction of collagen gel

Authors: Jae-Bum Jun, Young-In Na, Tae-Hwan Kim, Dae-Hyun Yoo

Published in: Rheumatology International | Issue 12/2010

Login to get access

Excerpt

Systemic sclerosis (SSc) is a connective tissue disease characterized by vasculopathy, excessive accumulation of extracellular matrix (ECM), and fibrosis of the skin and internal organs [1]. Although the precise etiology of SSc is still unknown, it is generally accepted that many types of cells are involved in the development and progression of SSc. Myofibroblasts, specialized contractile cells differentiated from fibroblasts, are believed to be the major cells with great importance in all forms of fibrotic diseases including SSc [2]. They have the morphological features intermediate between those of fibroblasts and smooth muscle cells and characteristically express alpha-smooth muscle actin (α-SMA) [3]. …
Literature
1.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
2.
go back to reference Abraham DJ, Eckes B, Rajkumar V, Krieg T (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9:136–143CrossRefPubMed Abraham DJ, Eckes B, Rajkumar V, Krieg T (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9:136–143CrossRefPubMed
3.
go back to reference Evans RA, Tian YC, Steadman R, Phillips AO (2003) TGF-beta1-mediated fibroblast–myofibroblast terminal differentiation—the role of Smad proteins. Exp Cell Res 282:90–100CrossRefPubMed Evans RA, Tian YC, Steadman R, Phillips AO (2003) TGF-beta1-mediated fibroblast–myofibroblast terminal differentiation—the role of Smad proteins. Exp Cell Res 282:90–100CrossRefPubMed
4.
go back to reference Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19–34CrossRefPubMed Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19–34CrossRefPubMed
5.
go back to reference Duthie G, Crozier A (2000) Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care 3:447–451CrossRefPubMed Duthie G, Crozier A (2000) Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care 3:447–451CrossRefPubMed
6.
go back to reference Ricupero DA, Poliks CF, Rishikof DC, Kuang PP, Goldstein RH (2001) Apigenin decreases expression of the myofibroblast phenotype. FEBS Lett 506:15–21CrossRefPubMed Ricupero DA, Poliks CF, Rishikof DC, Kuang PP, Goldstein RH (2001) Apigenin decreases expression of the myofibroblast phenotype. FEBS Lett 506:15–21CrossRefPubMed
7.
go back to reference Shi-Wen X, Denton CP, Dashwood MR, Holmes AM, Bou-Gharios G, Pearson JD, Black CM, Abraham DJ (2001) Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1. J Invest Dermatol 116:417–425CrossRefPubMed Shi-Wen X, Denton CP, Dashwood MR, Holmes AM, Bou-Gharios G, Pearson JD, Black CM, Abraham DJ (2001) Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1. J Invest Dermatol 116:417–425CrossRefPubMed
8.
go back to reference Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, Katan MB (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 67:255–262PubMed Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, Katan MB (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 67:255–262PubMed
Metadata
Title
Dietary flavonoid apigenin inhibits endothelin-1-induced contraction of collagen gel
Authors
Jae-Bum Jun
Young-In Na
Tae-Hwan Kim
Dae-Hyun Yoo
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1285-9

Other articles of this Issue 12/2010

Rheumatology International 12/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine